###### 

Number of patients in pivotal trials submitted in MAAs to the EMA 2005--2009

  Region                     Number of patients   \%     Number of sites   \%     Number of patients per site
  -------------------------- -------------------- ------ ----------------- ------ -----------------------------
  EU/EEA/EFTA                231,369              38.8   16,063            36.5   14
  North America              209,750              35.2   19,362            44.0   11
  Central/South America      54,657               9.2    2,625             6.0    21
  Middle East/Asia/Pacific   46,505               7.9    2,577             5.9    18
  CIS region                 22,664               3.8    1,566             3.6    14
  Africa                     17,915               3      707               1.6    25
  Australia--New Zealand     8,678                1.5    919               2.1    9
  Eastern Europe--non EU     4,042                0.7    215               0.5    19
  Total                      595,580                     44,034                   

###### 

2005--2009

          No of CTs   No of sites   No of patients   No of patients per trial
  ------- ----------- ------------- ---------------- --------------------------
  China   17          185           4,417            260
  India   65          528           8,920            137
  Korea   58          291           3,320            57

Source: European Medicines Agency (EMA) clinical trials submitted in marketing authorization applications to the EMA overview of patient recruitment and the geographical location of investigator sites, 5 November 2010, EMA/INS/GCP/154352/2010 Compliance and Inspection

###### 

Subjects and sites by country for marketing applications approved in the fiscal year 2008

  Country         Number of patients   \% of total patients   Number of sites   \% of total sites   Number of patients per site
  --------------- -------------------- ---------------------- ----------------- ------------------- -----------------------------
  China           424                  0.5                    32                0.3                 13
  India           384                  0.4                    49                0.4                 8
  Korea           409                  0.4                    32                0.3                 13
  USA             40,039               43.1                   5,098             45.4                8
  All countries   92,859                                      11,227                                

Source: Challenges to FDA's ability to monitor and inspect foreign clinical trials, DHSS, June 2010
